MDimune Inc. enters into a Research Collaboration Agreement with Australian National University to collaborate on the development of therapeutics for age-related macular degeneration
October xxth, 2022 – MDimune Inc., a Korean biotech company developing BioDroneTM platform technology based on cell-derived vesicles (CDVs), announced a research collaboration agreement with the Clear Vision Research Lab (CVR Lab) at the Australian National University (ANU), experts in retinal degenerations.